CD8A and hepatocellular carcinoma: In agreement with these results, a recent report showed that ARI-4175, a pan inhibitor of the DPP4 enzyme family, enhanced CD8+ T cell recruitment and activated intrahepatic inflammasome in a murine model of HCC [46].